Abstract
A series of 6 tricyclic partial ergoline derivatives was analyzed using radioligand binding assays. Four agents (LY 178210, LY 254089, LY 197205, and LY 197206) display high affinity (K i 1.3 nM) for 5-hydroxytryptamine 1A (5-HT 1A) receptor binding sites labeled by [ 3H] 8-hydroxy-2-(d1-n-propylamino) t tetralin (8-OH-DPAT) and display ⩾ 150 fold selectivity for the 5-HT 1A over the 5-HT 1D receptor binding site. The most potent agent investigated, LY 178210, is essentially inactive (K i > 1500 nM) at a total of 12 other neurotransmitter receptor binding sites in the brain. Using a forskolin-stimulated adenylate cyclase assay as a model of 5-HT 1A receptor function, LY 178210 was found to display partial agonist activity which was blocked by 10 −5 M (-) pindolol. These data indicate that LY 178210 is a potent and selective 5-HT 1A receptor partial agonist.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.